AIM ImmunoTech is a biopharmaceutical company based in North Brunswick, NJ, dedicated to developing innovative immunotherapy solutions for a wide range of debilitating and life-threatening conditions. Their lead program, Ampligen, is an immuno-modulator that has demonstrated broad spectrum activity in preclinical studies and is currently being evaluated in clinical trials for various diseases, including oncology, immune disorders, and viral diseases.
With a focus on improving patients' lives, AIM ImmunoTech aims to develop therapeutic solutions that have the potential to address unmet medical needs and provide better treatment options. Through their research and development efforts, they strive to advance the field of immunology and contribute to a better future for patients worldwide.
Generated from the website